Pricing Log in Create free account
Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%
Market cap
$34.8B
P/E
41.0×
Fwd P/E
31.5×
Dividend yield
—
F-score
4/9
Altman Z
3.13
Beneish M
−2.67
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Biogen Inc. (BIIB) Debt to equity

Alert me on Debt to equity

Biogen Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.4×, up 0.0× from fiscal 2025 (0.3×). Over the past ten years it has ranged from 0.3× (fiscal 2024) to 0.7× (fiscal 2015); the current reading is higher than 27% of that period. That is below the Drug Manufacturers General industry median of 0.6× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.3× 26.62%
FY2024 0.3× (40.70%)
FY2023 0.5× (2.22%)
FY2022 0.5× (18.06%)
FY2021 0.6× (17.61%)
FY2020 0.7× 107.87%
FY2019 0.3× (26.61%)
FY2018 0.5× (3.31%)
FY2017 0.5× (12.27%)
FY2016 0.5× (22.80%)

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.4× 14.71%
Mar 2026 0.3× (2.09%)
Dec 2025 0.3× (0.23%)
Sep 2025 0.3× (3.12%)
42 more quarters

Against its own ten years

Low 0.3× High 0.7×
Ten-year median 0.5×
Current reading's percentile 27

Debt to equity against peers

Company Debt to equity
SNY Sanofi compare 0.3×
BIIB Biogen Inc. 0.4×
AZN AstraZeneca PLC compare 0.6×
NVO Novo Nordisk A/S compare 0.6×
PFE Pfizer Inc. compare 0.7×
GSK GSK PLC Sponsored ADR compare 1.1×
BMY Bristol Myers Squibb Company compare 1.9×
GILD Gilead Sciences, Inc. compare 2.2×
AMGN Amgen Inc. compare 4.9×
Drug Manufacturers General industry median 0.6×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on BIIB